Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts

Journal of Applied Toxicology

Volumn 32, Issue 6, 2012, Pages 429-435

  Xu, Zhengli ^a   Liu, Changsheng ^b   Wei, Jie ^b   Sun, Jiao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cytochrome c; Hydroxyapatite nanoparticles; Inhibition; Osteoblast; P53; ROS

Indexed keywords

CYTOCHROME C; HYDROXYAPATITE; NANOCRYSTAL; NANOPARTICLE; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; GROWTH INHIBITION; NONHUMAN; OSTEOBLAST; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALKALINE PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; CRYSTALLIZATION; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; DURAPATITE; NANOPARTICLES; OSTEOBLASTS; OXIDATIVE STRESS; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 84860228570     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1745     Document Type: Article

References (24)

1. Ahamed MA. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol. 233: 404-410.
2. Bing W. 2009. Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice. J. Nanopart. Res. 11: 41-53.
3. Chen XJ, Deng CS, Tang SL. 2007. Mitochondria-dependent apoptosis induced by nanoscale hydroxapatite in human gastric cancer SGC-7901 cells. Biol. Pharm. Bull. 1: 128-132.
4. Ding TT, Sun J. 2007. Effect on nanometer hydroxypatitie particles on rat macrophage at mRNA level. Key Engng Mater. 330-332: 287-290.
5. Huang J, Best SM, Bonfield W, Brooks RA, Rushton N, Jayasinghe SN, Edirisinghe MJ. 2004. In vitro assessment of the biological response to nano-sized hydroxyapatite. J. Mater. Sci. Mater. Med. 4: 441-445.
6. Huang ZR, Hua SC, Yang YL, Fang JY. 2008.Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin. 29: 1094-1102.
7. Hung HS, Wu CC, Chien S, Hsu SH. 2009. The behavior of endothelial cells on polyurethane nanocomposites and the associated signaling pathways. Biomaterials 30: 1502-1511.
8. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. 2005. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Cancer Res. 65: 7436-7445.
9. Jin CY, Zhu BS, Wang XF. 2008. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem. Res. Toxicol. 21: 1871-1877.
10. Kwon JT, Hwang SK, Jin H. 2008. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J. Occup. Health 50: 1-6.
11. Tapan K, Jain. Maram, Reddy K. 2008. Biodistribution, Clearance, and Biocompatibilityof Iron Oxide Magnetic Nanoparticles in Rats. Mol. Pharmaceutics 5: 316-327.
12. Lee KW, Wang S, Yaszemski MJ, Lu L. 2008. Physical properties and cellular responses to crosslinkable poly (propylene fumarate)/hydroxyapatite nanocomposites. Biomaterials 29: 2839-2848.
13. Liu ZS, Tang SL, Ai ZL. 2003. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J. Gastroenterol. 9: 1968-1971.
14. Mo Y, Wan R, Chien S, Tollerud DJ, Zhang Q. 2009. Activation of endothelial cells after exposure to ambient ultrafine particles: the role of NADPH oxidase. Toxicol. Appl. Pharmacol. 236: 183-193.
15. Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 64: 609-615.
16. Moroni A, Pegreffi F, Cadossi M, Hoang-Kim A, Lio V, Giannini OS. 2005. Hydroxyapatite-coated external fixation pins. Expert Rev. Med. Devic. 2: 465-471.
17. Ok YJ, Myoung H, Kim YK, Lee JH, Kim MJ, Yun PY. 2010. Apoptotic effect of CKD-602 (Camtobell®) on oral squamous cell carcinoma cell lines. Oral Oncol. 45: 266-272.
18. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. 1990. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 3: 420-430.
19. Park EJ, Cho WS, Jeong J, Yi J, Choi K, Park K. 2009. Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 259: 113-121.
20. Rogers EJ, Hsieh SF, Organti N. 2008. A high throughput in vitro analytical approach to screen for oxidative stress potential exerted by nanomaterials using a biologically relevant matrix: human blood serum. Toxicol. Vitro 22: 1639-1647.
21. Shirkhanzadeh M. 2005. Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose. J. Mater. Sci. Mater. Med. 16: 37-45.
22. Wahl DA, Czernuszka JT. 2006. Collagen-hydroxyapatite composites for hard issue repair. Eur. Cell. Mater. 11: 43-56.
23. Ying Z, Kampfrath T, Thurston G, Farrar B, Lippmann M. 2009. Ambient particulates alter vascular function through induction of reactive oxygen and nitrogen species. Toxicol. Sci. 111(1): 80-88.
24. Yuan Y, Liu CS. 2002.Synthesis of nanometer hydroxyapatite by sol-gel method. Acta Acad. Med. Sin. 2: 129-133.